(Q37799943)

23 August 2017

Cancer of unknown primary site: 20 questions to be answered (English)

1 reference

23 August 2017

N Pavlidis

1

1 reference

PubMed ID

20943633

23 August 2017

G Pentheroudakis

series ordinal

2

1 reference

23 August 2017

1 October 2010

1 reference

23 August 2017

1 reference

23 August 2017

21 Suppl 7

1 reference

23 August 2017

vii303-7

1 reference

Carcinoma of unknown primary (CUP).

23 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ278

Diagnostic and therapeutic management of cancer of an unknown primary

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ278

Pathologic evaluation of unknown primary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ278

Molecular classification of unknown primary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ278

Switching benchmarks in cancer of unknown primary: from autopsy to microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ278

Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: active, but how effective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ278

Axillary nodal metastases from carcinoma of unknown primary (CUPAx): a systematic review of published evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ278

Neuroendocrine carcinoma of unknown primary site

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ278

Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ278

Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ278

Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ278

Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ278

Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ278

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDQ278

1 reference

23 August 2017

1 reference

PubMed ID

20943633